The American patent on Human Growth Hormone—useful for fighting wasting diseases associated with AIDS—expired in 2003. So why isn’t there a far-less-expensive "generic" version available in the US? Because HGH is a protein "biologic" drug, and protein drugs are far more difficult to produce than "small molecule" drugs, and the FDA says it can’t be certain that the generic versions are identical to the originals.
...
Complete entry
IEET Blog